ET-13RETROVIRAL REPLICATING VECTOR (RRV)-MEDIATED PRODRUG ACTIVATOR GENE THERAPY WITH CODON-OPTIMIZED NITROREDUCTASE IN EXPERIMENTAL GLIOMA.

S Collins; C Logg; A Inagaki; S Kamijima; P Lehouritis; P Searle; M Tangney; N Kasahara

doi:10.1093/neuonc/nou255.13

ET-13RETROVIRAL REPLICATING VECTOR (RRV)-MEDIATED PRODRUG ACTIVATOR GENE THERAPY WITH CODON-OPTIMIZED NITROREDUCTASE IN EXPERIMENTAL GLIOMA.

S Collins
, C Logg
, A Inagaki
, S Kamijima
, P Lehouritis
, P Searle
, M Tangney
, N Kasahara

College of Medicine and Health Office

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Neuro-Oncology
DOIs	https://doi.org/10.1093/neuonc/nou255.13 https://doi.org/10.1093/neuonc/nou255.13
Publication status	Published - Nov 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Cytosine deaminase
Prodrug
Genetic enhancement
Viral vector
Molecular biology
Cytotoxicity
Biology
Glioma
Cancer research
In vitro
Gene
Chemistry
Biochemistry
Recombinant DNA

Access to Document

https://openalex.org/W2315356525Licence: CC BY-NC-ND

Cite this

@article{ee93d10b19584b948453ce71abdbb47c,

title = "ET-13RETROVIRAL REPLICATING VECTOR (RRV)-MEDIATED PRODRUG ACTIVATOR GENE THERAPY WITH CODON-OPTIMIZED NITROREDUCTASE IN EXPERIMENTAL GLIOMA.",

keywords = "Cytosine deaminase, Prodrug, Genetic enhancement, Viral vector, Molecular biology, Cytotoxicity, Biology, Glioma, Cancer research, In vitro, Gene, Chemistry, Biochemistry, Recombinant DNA",

author = "S Collins and C Logg and A Inagaki and S Kamijima and P Lehouritis and P Searle and M Tangney and N Kasahara",

year = "2014",

month = nov,

doi = "10.1093/neuonc/nou255.13",

language = "English",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - ET-13RETROVIRAL REPLICATING VECTOR (RRV)-MEDIATED PRODRUG ACTIVATOR GENE THERAPY WITH CODON-OPTIMIZED NITROREDUCTASE IN EXPERIMENTAL GLIOMA.

AU - Collins, S

AU - Logg, C

AU - Inagaki, A

AU - Kamijima, S

AU - Lehouritis, P

AU - Searle, P

AU - Tangney, M

AU - Kasahara, N

PY - 2014/11

Y1 - 2014/11

KW - Cytosine deaminase

KW - Prodrug

KW - Genetic enhancement

KW - Viral vector

KW - Molecular biology

KW - Cytotoxicity

KW - Biology

KW - Glioma

KW - Cancer research

KW - In vitro

KW - Gene

KW - Chemistry

KW - Biochemistry

KW - Recombinant DNA

UR - http://europepmc.org/abstract/PMC/PMC4218108

U2 - 10.1093/neuonc/nou255.13

DO - 10.1093/neuonc/nou255.13

M3 - Article

SN - 1522-8517

JO - Neuro-Oncology

JF - Neuro-Oncology

ER -

ET-13RETROVIRAL REPLICATING VECTOR (RRV)-MEDIATED PRODRUG ACTIVATOR GENE THERAPY WITH CODON-OPTIMIZED NITROREDUCTASE IN EXPERIMENTAL GLIOMA.

UN SDGs

Keywords

Access to Document

Other files and links

Cite this